Literature DB >> 12610533

The genetics and genomics of cancer.

Allan Balmain1, Joe Gray, Bruce Ponder.   

Abstract

The past decade has seen great strides in our understanding of the genetic basis of human disease. Arguably, the most profound impact has been in the area of cancer genetics, where the explosion of genomic sequence and molecular profiling data has illustrated the complexity of human malignancies. In a tumor cell, dozens of different genes may be aberrant in structure or copy number, and hundreds or thousands of genes may be differentially expressed. A number of familial cancer genes with high-penetrance mutations have been identified, but the contribution of low-penetrance genetic variants or polymorphisms to the risk of sporadic cancer development remains unclear. Studies of the complex somatic genetic events that take place in the emerging cancer cell may aid the search for the more elusive germline variants that confer increased susceptibility. Insights into the molecular pathogenesis of cancer have provided new strategies for treatment, but a deeper understanding of this disease will require new statistical and computational approaches for analysis of the genetic and signaling networks that orchestrate individual cancer susceptibility and tumor behavior.

Entities:  

Mesh:

Year:  2003        PMID: 12610533     DOI: 10.1038/ng1107

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  159 in total

1.  Terminological mapping for high throughput comparative biology of phenotypes.

Authors:  Y A Lussier; J Li
Journal:  Pac Symp Biocomput       Date:  2004

2.  The prediction of disease risk in genomic medicine.

Authors:  Wayne D Hall; Katherine I Morley; Jayne C Lucke
Journal:  EMBO Rep       Date:  2004-10       Impact factor: 8.807

3.  DNA methylation patterns in alcoholics and family controls.

Authors:  Manish Thapar; Jonathan Covault; Victor Hesselbrock; Herbert L Bonkovsky
Journal:  World J Gastrointest Oncol       Date:  2012-06-15

4.  Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility.

Authors:  Stefan Kammerer; Richard B Roth; Carolyn R Hoyal; Richard Reneland; George Marnellos; Marion Kiechle; Ulrike Schwarz-Boeger; Lyn R Griffiths; Florian Ebner; Joachim Rehbock; Charles R Cantor; Matthew R Nelson; Andreas Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 5.  Ligand-targeted delivery of therapeutic siRNA.

Authors:  Yutaka Ikeda; Kazunari Taira
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.

Authors:  Stephen J Chanock; Laurie Burdett; Meredith Yeager; Victor Llaca; Anita Langerød; Shafaq Presswalla; Rolf Kaaresen; Robert L Strausberg; Daniela S Gerhard; Vessela Kristensen; Charles M Perou; Anne-Lise Børresen-Dale
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

7.  Clinical implication of centrosome amplification in plasma cell neoplasm.

Authors:  Wee J Chng; Greg J Ahmann; Kim Henderson; Rafael Santana-Davila; Philip R Greipp; Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Shaji Kumar; S Vincent Rajkumar; John A Lust; Robert A Kyle; Steven R Zeldenrust; Suzanne R Hayman; Rafael Fonseca
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

Review 8.  Proteomic technology for biomarker profiling in cancer: an update.

Authors:  Moulay A Alaoui-Jamali; Ying-jie Xu
Journal:  J Zhejiang Univ Sci B       Date:  2006-06       Impact factor: 3.066

Review 9.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

Review 10.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.